ImmunityBio
IBRX
IBRX
239 hedge funds and large institutions have $328M invested in ImmunityBio in 2025 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 103 increasing their positions, 37 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.74% more ownership
Funds ownership: 9.32% → 14.06% (+4.7%)
3% less call options, than puts
Call options by funds: $11.9M | Put options by funds: $12.2M
Holders
239
Holding in Top 10
1
Calls
$11.9M
Puts
$12.2M
Top Buyers
| 1 | +$22.1M | |
| 2 | +$20.9M | |
| 3 | +$20.4M | |
| 4 |
BlackRock
New York
|
+$12M |
| 5 |
AC
AlphaCore Capital
La Jolla,
California
|
+$8M |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$1.53M | |
| 3 | -$715K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$666K |
| 5 |
Citigroup
New York
|
-$612K |